Tower Research Capital LLC (TRC) - CANDEL THERAPEUTICS INC ownership

CANDEL THERAPEUTICS INC's ticker is and the CUSIP is 137404109. A total of 21 filers reported holding CANDEL THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of CANDEL THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$7,955
-23.6%
8,647
+4.7%
0.00%
Q2 2023$10,410
+115566.7%
8,262
+25.6%
0.00%
Q1 2023$9
-30.8%
6,576
-8.8%
0.00%
-100.0%
Q4 2022$13
-99.9%
7,214
+74.4%
0.00%
Q3 2022$13,000
+225.0%
4,137
+239.4%
0.00%
Q2 2022$4,0001,219
+2157.4%
0.00%
Q1 2022$0540.00%
Other shareholders
CANDEL THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Northpond Ventures, LLC 1,935,215$1,780,3985.13%
Sands Capital Ventures, LLC 811,737$746,7980.22%
Empirical Asset Management, LLC 10,000$9,2000.01%
Baystate Wealth Management LLC 97,310$89,5250.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 132,595$123,3130.00%
FRANKLIN RESOURCES INC 1,125,000$1,046,2500.00%
OneDigital Investment Advisors LLC 25,428$23,3940.00%
WELLS FARGO & COMPANY/MN 108$990.00%
NORTHERN TRUST CORP 19,617$18,0480.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of CANDEL THERAPEUTICS INC shareholders